Sympathotonic orthostatic hypotension (SOH) is an idiopathic syndrome chara
cterized by tachycardia, hypotension, elevated plasma norepinephrine, and s
ymptoms of orthostatic intolerance provoked by assumption of an upright pos
ture. We studied a woman with severe progressive SOH with blood pressure un
responsive to the presser effects of alpha (1)-adrenergic receptor (AR) ago
nists, We tested the hypothesis that a circulating factor in this patient i
nterferes with vascular adrenergic neurotransmission. Preincubation of porc
ine pulmonary artery vessel rings with patient plasma produced a dose-depen
dent inhibition of vasoconstriction to phenylephrine in vitro, abolished va
soconstriction to direct electrical stimulation, and had no effect on nonad
renergic vasoconstrictive stimuli (endothelin-1), PGF-2 alpha (or KCl), Pre
incubation of vessels with control plasma was devoid of these effects. SOH
plasma inhibited the binding of an alpha (1)-selective antagonist radioliga
nd ([I-125]HEAT) to membrane fractions derived from porcine pulmonary arter
y vessel rings, rat liver, and cell lines selectively overexpressing human
ARs of the alpha (1B) subtype but not other AR subtypes (alpha (1A) and alp
ha (1D)), We conclude that a factor in SOH plasma can selectively and irrev
ersibly inhibit adrenergic ligand binding to alpha (1B) ARs, We propose tha
t this factor contributes to a novel pathogenesis for SOH in this patient.
This patient's syndrome represents a new disease entity, and her plasma may
provide a unique tool for probing the selective functions of alpha (1)-ARs
.